Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Golimumab

Brand: SimponiĀ®
NICE TA: 
Indication: Second line biologic for moderate to severe active ulcerative colitis ONLY where patients have had adalimumab 1st line .
Disease category: Gastro-intestinal system
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Infliximab or golimumab may be used as a second line biologic in UC ONLY where patients have had adalimumab 1st line.

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

Gastroenterology Biologics Pathway (Version 1.1) (355.6 KiB)

 

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red